Philip Morris International to Manufacture Cigarettes for Altria in U.S.
Event summary
- Philip Morris International (PMI) has entered a contract manufacturing agreement with Altria’s Philip Morris USA for combustible cigarettes in the U.S.
- The arrangement leverages PMI’s non-U.S. affiliates and Altria’s U.S. manufacturing expertise, with first shipments expected in early 2027.
- PMI will not commercialize cigarettes in the U.S. and will maintain independent operations with Altria.
- The deal is not expected to materially impact PMI’s 2026 financials.
The big picture
This deal marks a strategic pivot for PMI, which has long focused on transitioning away from combustible cigarettes. While the arrangement is purely operational, it underscores the complexities of navigating regulatory and market dynamics in the U.S. tobacco industry. PMI’s smoke-free products accounted for 42% of its Q2 2026 net revenues, highlighting the tension between legacy and future-focused business models.
What we're watching
- Regulatory Compliance
- Whether the arrangement will face regulatory hurdles given PMI’s focus on smoke-free products.
- Strategic Alignment
- How this collaboration affects PMI’s long-term smoke-free transition goals.
- Operational Efficiency
- The pace at which PMI and Altria can integrate manufacturing capabilities without disrupting existing operations.